| CKPT Stock | | | USD 4.39 0.11 2.57% |
Checkpoint Therapeutics financial indicator trend analysis is way more than just evaluating Checkpoint Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Checkpoint Therapeutics is a good investment. Please check the relationship between Checkpoint Therapeutics Long Term Debt Total and its Accounts Payable accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Checkpoint Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in american community survey.
For more information on how to buy Checkpoint Stock please use our
How to Invest in Checkpoint Therapeutics guide.
Long Term Debt Total vs Accounts Payable
Long Term Debt Total vs Accounts Payable Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Checkpoint Therapeutics Long Term Debt Total account and
Accounts Payable. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Checkpoint Therapeutics' Long Term Debt Total and Accounts Payable is -0.16. Overlapping area represents the amount of variation of Long Term Debt Total that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Checkpoint Therapeutics, assuming nothing else is changed. The correlation between historical values of Checkpoint Therapeutics' Long Term Debt Total and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt Total of Checkpoint Therapeutics are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Long Term Debt Total i.e., Checkpoint Therapeutics' Long Term Debt Total and Accounts Payable go up and down completely randomly.
Correlation Coefficient | -0.16 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Long Term Debt Total
Accounts Payable
An accounting item on the balance sheet that represents Checkpoint Therapeutics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Checkpoint Therapeutics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from Checkpoint Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Checkpoint Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Checkpoint Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in american community survey.
For more information on how to buy Checkpoint Stock please use our
How to Invest in Checkpoint Therapeutics guide.
Sales General And Administrative To Revenue is likely to gain to 88.54 in 2024, whereas
Selling General Administrative is likely to drop slightly above 7.3
M in 2024.
Checkpoint Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Checkpoint Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Checkpoint Therapeutics fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Checkpoint Stock Analysis
When running Checkpoint Therapeutics' price analysis, check to
measure Checkpoint Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Checkpoint Therapeutics is operating at the current time. Most of Checkpoint Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Checkpoint Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Checkpoint Therapeutics' price. Additionally, you may evaluate how the addition of Checkpoint Therapeutics to your portfolios can decrease your overall portfolio volatility.